Interleukin-18 in hemophagocytic lymphohistiocytosis

Leukemia and Lymphoma

Volumn 42, Issue 1-2, 2001, Pages 21-28

  Takada, H ^a   Nomura, A ^a   Ohga, S ^a   Hara, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Hemophagocylic lymphohistiocytosis; IL 18

Indexed keywords

CYTOKINE; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 18; PLASMA PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIAGNOSTIC PROCEDURE; EVALUATION; HEMOPHAGOCYTIC SYNDROME; HISTIOCYTOSIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNOPATHOGENESIS; INFLAMMATION; LYMPHOCYTE ACTIVATION; MACROPHAGE; MEASUREMENT; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REGULATORY MECHANISM; REVIEW; SERUM; TH1 CELL;

EID: 0034926839     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109097673     Document Type: Review

References (74)

1. Virus-associated hemophagocytic syndrome. A benign histiocytic proliferation distinct from malignant histiocytosis
2. Histiocytes and histiocytosis
3. Lymphohistiocytic disorders
4. Hemophagocytic syndrome in children and adults
5. Genetic basis of hemophagocytic lymphohistiocytosis syndrome
6. Perforin gene defects in familial hemophagocytic lymphohistiocytosis
7. Perforin: More than just an effector molecule
8. A role for perforin in activation-induced T cell death in vivo: Increased expansion of allogeneic perforin-deficient T cells in SCID mice
9. Theiler's virus infection of perforin-deficient mice
10. A role for perforin in downregulating T-cell responses during chronic viral infection
11. Perforin pathway is essential for protection of mice against lethal ocular HSV-1 challenge but not corneal scarring
12. Differential diagnosis of hemophagocytic syndrome: Underlying disorders and selection of the most effective treatment
13. Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance
14. Serum levels of interferon-gamma, cytotoxic factor and soluble interleukin-2 receptor in childhood hemophagocytic syndromes
15. Hypercytokinemia in familial hemophagocytic lymphohistiocytosis
16. Clinicopathological diagnosis and treatment of malignant histiocytosis
17. Elevated soluble interleukin-2 receptor in childhood hemophagocytic histiocytic syndromes
18. Cytokine production regulating Th1 and Th2 cytokines in hemophagocytic lymphohistiocytosis
19. Prognosis of children with virus-associated hemophagocytic syndrome and malignant histiocytosis: Correlation with levels of serum interleukin-1 and tumor necrosis factor
20. Involvement of interferon-γ and macrophage colony-stimulation factor in pathogenesis of haemophagocytic lymphohistiocytosis in adults
21. Endotoxin- induced serum factor that stimulates gamma interferon production
22. Upregulation of tumor necrosis factor-α in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome
23. Inflammatory cytokines in virus-associated hemophagocytic syndrome
24. Hypercytokinemia in hemophagocytic syndrome
25. Elevation of the serum Fas ligand in patients with hemophagocytic syndrome and Diamond-Blackfan anemia
26. Purification of a factor which provides a costimulatory signal for γ interferon production
27. Cloning of a new cytokine that induced IFN-γ production by T cells
28. Production of IL-18 (IFN-γ -inducing factor) mRNA and functional protein by murine keratinocytes
29. IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses
30. Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation
31. Immunohistochemical and immune-electron-microscopic detection of interferon-γ -inducing factor ("interleukin-18") in mouse intestinal epithelial cells
32. Airway epithelium expresses interleukin-18
33. Cloning of rat brain interleukin-18 cDNA
34. Modulation of IL-18 production in the adrenal cortex following acute ACTH or chronic corticosterone treatment
35. Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme
36. Cloning of the cDNA for human IFN-γ-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein
37. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferon-gamma production
38. + T cells but induces type 1 T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells
39. IFN-γ -inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12
40. + human blood mononuclear cells
41. IFN-γ -inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones
42. Involvement of the CD95 (Apo-1/Fas) receptor and ligand in liver damage
43. Fas ligand in human serum
44. Essential roles of Fas ligand in the development of hepatitis
45. Interferon-γ -inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper cells
46. Interleukin-18 activates NF-kB in murine T helper type1 cells
47. Interleukin-18/interferon-gamma-inducing factor, a novel cytokine, up-regulates ICAM-1 (CD54) expression in KG-1 cells
48. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice
49. Interleukin-18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium
50. Role of endogenous interleukin-18 in resolving wild-type and attenuated Salmonella typhimurium infections
51. Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice
52. Interleukin-18 protects mice against acute herpes simplex virus type 1 infection
53. IL-12-independent Th1-type immune responses to respiratory viral infection: Requirement of IL-18 for IFN-gamma release in the lung but not for the differentiation of viral-reactive Th1-type lymphocytes
54. Combined effects of IL-12 and IL-18 on the induction of collagen-induced arthritis
55. IFN-gamma-inducing factor (IL-18) increases allergic sensitization, serum IgE, Th2 cytokines, and airway eosinophilia in a mouse model of allergic asthma
56. Ischemia/reperfusion-induced IFN-gamma up-regulation: Involvement of IL-12 and IL-18
57. Role of interleukin-18 (IL-18) during lethal shock: Decreased lipopolysaccharide sensitivity but normal superantigen reaction in IL-18-deficient mice
58. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection
59. Increased levels of circulating interleukin-18 in patients with advanced tuberculosis
60. Interferon-gamma-inducing factor (IL-18) and interferon-gamma in inflammatory CNS diseases
61. A proinflammatory role for IL-18 in rheumatoid arthritis
62. Bioactive IL-18 expression is up-regulated in Crohn's disease
63. Elevated plasma concentrations of interferon (IFN)-gamma and the IFN-gamma-inducing cytokines interleukin (IL)-18, IL-12, and IL-15 in severe melioidosis
64. Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection
65. Elevation of serum interleukin-18 levels and activation of Kupffer cells in biliary atresia
66. IL-18 in pregnancy; The elevation of IL-18 in maternal peripheral blood during labour and complicated pregnancies
67. Oversecretion of IL-18 in haemophagocytic lymphohistiocytosis: A novel marker of disease activity
68. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice
69. Expression of the Fas ligand in cells of T cell lineage
70. Regulation of Fas and Fas-ligand expression in NK cells by cytokines and the involvement of Fas-ligand in NK/LAK cell-mediated cytotoxicity
71. Hemophagocytic lymphohistiocytosis. Report of children from the International Registry
72. Hemophagocytic lymphohistiocytosis in infancy and childhood
73. Defective NK cell activity and Th1 response in IL-18-deficient mice
74. Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor